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Introduction
Cell migration involves membrane polarization and cytoskele-
tal dynamics, both of which are regulated by Rho family GTPases 
(Raftopoulou and Hall, 2004). Among these molecules, Rac is 
crucial for generating the actin-rich lamellipodial protrusion, 
which is a principal part of the driving force for   movement. Rac 
is composed of three isoforms, Rac1, Rac2, and Rac3. Rac1 is 
ubiquitously expressed and Rac3 is highly expressed in  the 
brain, whereas Rac2 expression is largely restricted to hemato-
poietic cells. The role of Rac in neutrophil functions has been 
extensively analyzed with knockout mice lacking Rac1 and/or 
Rac2, and in a human patient with a point mutation in the con-
served GTP-binding domain of Rac2. These studies clearly 
  indicate that Rac2 is a major Rac isoform that regulates 
chemoattractant-induced neutrophil functions, such as chemo-
taxis and superoxide production (Roberts et al., 1999; Williams 
et al., 2000; Gu et al., 2003). However, the defects in chemo-
taxis and superoxide production of Rac2-defi  cient neutrophils 
are signifi  cantly augmented by additional loss of Rac1 (Gu 
et al., 2003). In addition, it has been reported that Rac1 defi  -
ciency alone results in an inability of neutrophils to detect and 
to orient in a chemotactic gradient (Sun et al., 2004), suggest-
ing that Rac1 is also involved in the chemotactic   response of 
murine neutrophils.
Like other Rho family GTPases, Rac cycles between 
GDP-bound inactive and GTP-bound active states. Because the 
GTP loading is mediated by guanine nucleotide exchange fac-
tors (GEFs), signifi  cant efforts have been made to identify a Rac 
GEF that functions downstream of chemoattractant receptors in 
neutrophils. P-Rex1 is a phosphatidylinositol 3,4,5-triphosphate 
(PIP3)– and Gβγ-regulated Rac GEF that has been purifi  ed from 
neutrophils (Welch et al., 2002). It had been thought that P-Rex1 
would be a major Rac activator that regulates neutrophil 
  chemotaxis. Unexpectedly, however, it was recently found that 
neutro  phil chemotaxis is only mildly affected in P-Rex1–
 defi  cient (P-Rex1
−/−) neutrophils (Dong et al., 2005; Welch 
et al., 2005). In addition, chemoattractant-induced Rac activation 
was also reported to occur normally in neutrophils lacking both 
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eutrophils are highly motile leukocytes, and they 
play important roles in the innate immune response 
to invading pathogens. Neutrophil chemotaxis 
requires Rac activation, yet the Rac activators function-
ing downstream of chemoattractant receptors   remain to 
be determined. We show that DOCK2, which is a mam-
malian homologue of Caenorhabditis elegans CED-5 and 
Drosophila melanogaster Myoblast City,   regulates motil-
ity and polarity during neutrophil chemotaxis. Although 
DOCK2-deﬁ  cient neutrophils moved   toward the chemo-
attractant source, they exhibited abnormal   migratory be-
havior with a marked reduction in   translocation speed. 
In DOCK2-deﬁ  cient neutrophils, chemoattractant-induced 
activation of both Rac1 and Rac2 were severely impaired, 
resulting in the loss of polarized accumulation of F-actin 
and phosphatidylinositol 3,4,5-triphosphate (PIP3) at the 
leading edge. On the other hand, we found that DOCK2 
associates with PIP3 and translocates to the leading edge 
of chemotaxing neutrophils in a phosphatidylinositol 
  3-kinase (PI3K)–  dependent manner. These results indicate 
that during neutrophil chemotaxis DOCK2 regulates lead-
ing edge formation through PIP3-dependent membrane 
translocation and Rac activation.
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Vav1 and Vav3 (Gakidis et al., 2004). Thus, the Rac activator that 
is critical for neutrophil chemotaxis remains to be determined.
CDM family proteins (Caenorhabditis elegans CED-5, 
mammalian DOCK180, and Drosophila melanogaster Myo-
blast City) are known to regulate the actin cytoskeleton by func-
tioning upstream of Rac (Wu and Horvitz, 1998). DOCK2 is 
a new member of the CDM family proteins, and is expressed 
predominantly in hematopoietic cells (Fukui et al., 2001). 
  Although DOCK2 does not contain the Dbl homology domain 
and the pleckstrin homology (PH) domain that are typically 
found in GEFs, DOCK2 binds to nucleotide-free Rac and cata-
lyzes GTP loading through its Docker (also known as DHR-2) 
domain (Brugnera et al., 2002; Côté and Vuori, 2002). We had 
previously reported that DOCK2 regulates lymphocyte migra-
tion and immunological synapse formation through Rac activa-
tion (Fukui et al., 2001; Sanui et al., 2003a). However, the role 
of DOCK2 in neutrophils remains unknown, an issue that was 
addressed in this study.
Results and discussion
To examine whether DOCK2 functions in neutrophils, we fi  rst 
compared Rac activation between C57BL/6 (B6) and DOCK2
−/− 
mice. When bone marrow (BM) neutrophils from B6 mice 
were stimulated with N-formyl-methionyl-leucyl-phenylalanine 
(fMLP), activated Rac1, Rac2, and Cdc42 were readily detected 
at 5 s after stimulation (Fig. 1 A). This activation was rapid and 
transient, and the levels of the GTP-bound Rac1, Rac2, and 
Cdc42 were substantially decreased at 15 s. In DOCK2
−/− neu-
trophils, Cdc42 was activated to the same extent and at the same 
kinetics as in B6 neutrophils (Fig. 1 A). However, fMLP- induced 
activation of both Rac1 and Rac2 were reduced by 70% 
in DOCK2
−/− neutrophils at 5 s after stimulation (Fig. 1 A). 
  Similar defects were observed when DOCK2
−/− neutrophils 
were stimulated with PMA (Fig. S1, available at http://www.
jcb.org/cgi/content/full/jcb.200602142/DC1). These results in-
dicate that DOCK2 plays a major role in chemoattractant- and 
PMA-induced Rac activation in neutrophils.
We next examined how DOCK2 defi  ciency affects neutro-
phil functions. In the transwell chemotaxis assay, 8–11% of B6 
BM neutrophils migrated into the lower chamber in response 
to 8 μM fMLP (Fig. 1 B, left). In the case of DOCK2
−/− neutro-
phils, however, the percentage of migrating cells was <2% 
  under the same conditions (Fig. 1 B, left). A similar defect was 
observed when complement factor 5a (C5a) was used as a 
  chemoattractant (Fig. 1 B, right). When B6 BM neutrophils 
were stimulated with fMLP, they produced superoxides in a 
superoxide dismutase (SOD)–inhibitable manner (Fig. 1 C, 
left). However, the total amount of superoxides produced by 
DOCK2
−/− neutrophils was reduced to <20% of the wild-type 
level (Fig. 1 C, left). In addition, unlike P-Rex1
−/− neutrophils 
(Dong et al., 2005; Welch et al., 2005), DOCK2
−/− neutrophils 
exhibited a defect in PMA-induced superoxide production (Fig. 
1 C, right). These results indicate that DOCK2 is required in 
neutrophils for chemotaxis and superoxide production.
To determine more precisely the role of DOCK2 in neu-
trophil chemotaxis, we analyzed BM neutrophils undergoing 
chemotaxis in a Zigmond chamber containing the fMLP gradient. 
At fi  rst glance, DOCK2
−/− neutrophils were less motile than 
B6  neutrophils (Video 1, available at http://www.jcb.org/cgi/ 
content/full/jcb.200602142/DC1). Detailed analysis revealed 
that the average speed of DOCK2
−/− neutrophils was reduced 
to 55% of the wild-type level (Fig. 2 A). When the fi  nal location 
relative to the initial position was analyzed at 12.5 min, >85% 
of neutrophils had migrated toward the fMLP source, irrespec-
tive of DOCK2 expression (Fig. 2 B). However, although 
B6 neutrophils moved in relatively straight paths up the fMLP 
gradient, DOCK2
−/− neutrophils often showed indecisive wan-
dering behavior and took a turn in a short period (Video 2). 
Supporting this, DOCK2 defi  ciency was found to affect the 
Figure 1.  DOCK2 is a Rac activator that regulates chemotaxis and super-
oxide production in neutrophils. (A) BM neutrophils from B6 (+/+) and 
DOCK2
−/− (−/−) mice were stimulated with 8 μM fMLP for the indicated 
times and analyzed for activation of Rac1, Rac2, and Cdc42. Results were 
quantiﬁ  ed by densitometry and are expressed as the ratio of GTP-bound 
form to total protein after normalization of the 5-s value of B6 neutrophils 
to an arbitrary value of 1. The results indicate the mean ± the SD of three 
separate experiments. *, P < 0.01. (B) Chemotactic response of BM neu-
trophils to fMLP or C5a was compared between B6 and DOCK2
−/− mice 
in a transwell chemotaxis assay. The results are expressed as the percent-
age of the input cells (mean ± the SD of triplicate wells), and represent 
three separate experiments. (C) Superoxide production in response to 
8 μM fMLP or 200 ng/ml PMA was compared between B6 and DOCK2
−/− 
BM neutrophils. The results represent two separate experiments.ROLE OF DOCK2 IN NEUTROPHIL CHEMOTAXIS • KUNISAKI ET AL. 649
  directional change and the straightness during neutrophil 
  chemotaxis (Fig. 2 A).
To understand the mechanism by which DOCK2 regu-
lates neutrophil chemotaxis, we fi  rst examined actin polymer-
ization in BM neutrophils stimulated in suspension with fMLP. 
Although fMLP-induced actin polymerization is almost totally 
abolished in neutrophils lacking Rac1 and Rac2 (Gu et al., 
2003), such a drastic effect was not observed in DOCK2
−/− 
neutrophils (Fig. 2 C). This might result from the difference in 
Cdc42 activation because, unlike DOCK2 defi  ciency, Rac2 de-
fi  ciency has been reported to impair fMLP-induced Cdc42 acti-
vation in neutrophils (Sun et al., 2004). Microscopic analysis 
revealed that both B6 and DOCK2
−/− neutrophils uniformly ac-
cumulated F-actin at 15 s after stimulation (Fig. 2 D). However, 
although B6 neutrophils exhibited a localized accumulation 
of F-actin at 30 s, such polarization was scarcely found in 
DOCK2
−/− neutrophils, although there was partial recovery of 
F-actin polarity at 60 s (Fig. 2 D). Consistent with this fi  nding, 
the majority of DOCK2
−/− neutrophils undergoing chemotaxis 
exhibited aberrant morphology with poorly focused distribu-
tion of F-actin (Fig. 2, E and F). These results indicate that 
DOCK2 is required for polarized accumulation of F-actin at the 
leading edge.
In response to chemoattractants, neutrophils accumulate 
PIP3, which is a lipid product of phosphatidylinositol 3-kinases 
(PI3Ks), at the leading edge (Servant et al., 2000). Because this 
process requires Rac activation and actin polymerization (Wang 
et al., 2002; Srinivasan et al., 2003), we examined how DOCK2 
defi  ciency affects PIP3 accumulation by transiently expressing a 
GFP-tagged PH domain of Akt (PH-Akt), which is a widely 
used probe for detecting the spatial distribution of PIP3. When 
BM neutrophils were exposed to a uniform concentration of 
fMLP, PH-Akt rapidly translocated to the plasma membrane in 
both B6 and DOCK2
−/− neutrophils (Fig. 3 A). However, while 
B6 neutrophils accumulated PH-Akt at the plasma membrane in 
a highly asymmetric manner at 30 and 60 s after stimulation, the 
membrane accumulation of PH-Akt was impaired in DOCK2
−/− 
neutrophils at these time points (Fig. 3 A). Similar, but more 
profound, effects of DOCK2 defi  ciency were observed when 
BM neutrophils were stimulated with fMLP supplied by a mi-
cropipette (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200602142/DC1). Consistent with this defect, fMLP-
induced Akt phosphorylation was reduced in DOCK2
−/− neu-
trophils (Fig. 3 B). Thus far, Akt phosphorylation has been used 
as an indirect assay for PIP3 synthesis. Surprisingly, however, 
BM neutrophils from B6 and DOCK2
−/− mice comparably gen-
erated PIP3 in response to fMLP and C5a (Fig. 3 C and Fig. S3). 
These results suggest that DOCK2-mediated Rac activation 
regulates the persistent accumulation of PIP3 at the leading 
edge, independently of PI3K activities.
We then asked whether DOCK2 itself is recruited to the 
leading edge in response to chemoattractants. For this purpose, 
we developed knock-in mice, where the gene encoding GFP is 
inserted immediately after the last exon of DOCK2 with a 
 modifi  cation of the stop codon. When BM neutrophils of 
DOCK2-GFP mice were exposed to a uniform concentration 
of fMLP, DOCK2 rapidly translocated to the plasma membrane 
(Fig. 4 A, left). However, such translocation was totally 
Figure 2.  DOCK2 regulates motility and polarity during 
neutrophil chemotaxis. (A) BM neutrophils chemotaxing 
under the fMLP gradient were analyzed for speed, direc-
tional change, and straightness using time-lapse video 
  microscopy. Data were collected at 15-s intervals for 
12.5 min and processed with MetaMorph software. The 
directional change is a measure of the frequency of turns 
that a cell makes to move 100 μm in a given direction. 
Cells are judged to take a turn when the angle between 
the migration vector and the ﬁ  nal direction changes from 
a positive value to a negative one, and vice versa. The 
straightness was estimated by dividing the distance from 
the initial position to the ﬁ  nal location by the total path 
length. The results are expressed as the mean ± the SEM 
of seven separate experiments using age-matched mice. 
*, P < 0.001. (B) The ﬁ  nal location relative to the initial 
position is compared between B6 and DOCK2
−/− neutro-
phils (n  = 117). The crossmarks indicate the origin. 
(C and D) BM neutrophils were stimulated in suspension 
with 10 μM fMLP for the indicated times, and analyzed 
for the content (C) and localization (D) of F-actin by stain-
ing the cells with phalloidin. In C, the results are expressed 
as the mean channel ﬂ  uorescence (mean ± the SD of trip-
licate wells) and represent three separate experiments. 
*, P < 0.01. (E and F) BM neutrophils chemotaxing under 
the fMLP gradient were stained with phalloidin, and the 
percentages of neutrophils with polarized F-actin localiza-
tion were compared (n = 200). Cells are judged to be 
positive when F-actin staining is conﬁ  ned to less than one 
third of the circumference. Bars, 10 μm.JCB • VOLUME 174 • NUMBER 5 • 2006  650
  abolished by   pretreating the cells with a PI3K inhibitor wort-
mannin (Fig. 4 A, right). Although BM neutrophils polarized 
and accumulated DOCK2 at the leading edge in response to a 
point source of fMLP, the intracellular DOCK2 dynamics and 
morphological changes were severely impaired in cells pre-
treated with the PI3K inhibitors LY294002 and wortmannin 
(Fig. 4 B and not depicted). These results indicate that DOCK2 
translocates to the leading edge in a PI3K-dependent manner.
To elucidate the mechanism for PI3K-dependent intracel-
lular DOCK2 dynamics, we examined whether DOCK2 binds 
to PIP3 by expressing DOCK2 in human embryonic kidney 
(HEK) 293T cells with or without ELMO1, which is known to 
function cooperatively with DOCK2 in lymphocytes (Sanui 
et al., 2003b). When cell extracts expressing DOCK2 alone 
were precipitated with PIP3-coated beads, only a weak associa-
tion was found (Fig. 5 A). However, the association of DOCK2 
with PIP3 was signifi  cantly augmented by coexpression with 
ELMO1 (Fig. 5 A). DOCK2 was associated with PIP3, but not 
PI(3,4)P2 and PI(4,5)P2 (Fig. 5 B). This association seemed to 
be specifi  c because the PIP3 binding was inhibited when cell 
extracts were preincubated with PIP3-containing liposomes 
(Fig. 5 C). Recently, DHR-1, which is an evolutionarily con-
served domain among CDM family proteins, has been shown to 
play an important role in PIP3 binding of DOCK180 (Côté et al., 
2005). When a DOCK2 mutant lacking DHR-1 (DHR1del) was 
expressed in HEK293T cells with ELMO1, PIP3 binding was 
hardly detected (Fig. 5 D). This does not result from an inability 
to bind to ELMO1 because the deletion of DHR-1 does not affect 
DOCK2 binding to ELMO1 (unpublished data). Collectively, these 
results indicate that DOCK2 associates with PIP3 through DHR-1, 
and that this association is indirectly regulated by ELMO1.
Several lines of evidence indicate that a PIP3- and Rac-
  mediated positive-feedback loop is required for neutrophil che-
motaxis by amplifying chemoattractant signals at the leading 
edge (Weiner et al., 2002; Wang et al., 2002; Srinivasan et al., 
2003). We have shown that whereas DOCK2 translocates to the 
leading edge in a PI3K-dependent manner, DOCK2 activates 
Rac and stabilizes the accumulation of PIP3 at the leading edge. 
These results suggest that DOCK2, in some sense, regulates 
leading edge formation by functioning in a PIP3- and Rac-mediated 
feedback loop. However, it is unlikely that DOCK2-Rac signal-
ing affects the catalytic activities of PI3Ks because BM neutro-
phils from B6 and DOCK2
−/− mice comparably generated PIP3 
in response to chemoattractants. Thus far, it has been reported 
that an inhibitor of actin polymerization reduces insulin-mediated 
Akt phosphorylation and PH-Akt translocation, without affect-
ing PI3K activity, in cells other than neutrophils (Peyrollier 
et al., 2000). Similar fi  ndings have been reported in neutrophil-
like HL-60 cells stimulated with fMLP (Wang et al., 2002). 
On the other hand, we found that the persistence and   polarized 
distribution of PIP3 is correlated with the localized F-actin as-
sembly in fMLP-treated BM neutrophils. Although the precise 
meaning of this correlation remains unknown at this stage, the 
localized F-actin assembly might prevent PIP3   diffusion away 
Figure 3.  DOCK2 is important in stabilizing 
the accumulation of PIP3. (A) After transfection 
of  PH-Akt-GFP DNA, BM neutrophils were 
exposed to a uniform concentration of fMLP 
(10 μM), and analyzed for the membrane ac-
cumulation of PH-Akt at the indicated times. 
Bar, 10 μm. (B) BM neutrophils from B6 (+/+) 
and DOCK2
−/− (−/−) mice were stimulated 
with 10 μM fMLP for the indicated times and 
analyzed for Akt phosphorylation at Ser473 
and Thr308. Results are expressed as the ratio 
of phosphorylated Akt to total Akt after normal-
ization of the 30-s value of B6 neutrophils to 
an arbitrary value of 1. The results indicate 
mean  ± SD of three separate experiments. 
*, P < 0.01. (C) 
32Pi-labeled BM neutrophils 
were stimulated with 8 μM fMLP for 15 s, 
deacylated, and separated by HPLC. A repre-
sentative chromatogram showing the peaks 
corresponding to PIP3 (left) and the percentage 
of PIP3 to PI4P (right; mean ± the SD of tripli-
cate determination) are indicated. A sample 
of BM neutrophils treated with wortmannin be-
fore stimulation was included as a control.ROLE OF DOCK2 IN NEUTROPHIL CHEMOTAXIS • KUNISAKI ET AL. 651
from the leading edge and regulate activation of PIP3-binding 
proteins by facilitating the effective protein–protein or protein–
lipid interaction.
Materials and methods
Mice
DOCK2
−/− mice were backcrossed with B6 mice for more than eight gen-
erations before use. For development of DOCK2-GFP mice, a targeting 
vector was designed to insert the gene encoding GFP and a ﬂ   oxed-
  neomycin–resistant cassette (Neo) immediately after the last exon of DOCK2 
and was introduced into embryonic stem cells by electroporation. 
  Correctly targeted embryonic stem clones were microinjected into 
B6 blastocysts, and the male chimeras obtained were crossed with female 
B6 mice. Heterozygous mutant mice were crossed with Ella Cre mice to 
remove  Neo, and Neo-deleted heterozygous mutant mice were inter-
crossed to develop homozygous mutants expressing the DOCK2-GFP 
  chimeric molecule. All experiments were done in accordance with the 
guidelines of the committee of Ethics of Animal Experiments, Faculty of 
Medical Sciences, Kyushu University.
Isolation of BM neutrophils
BM cells were isolated from femurs and tibias of mice and layered onto the 
discontinuous Percoll (Sigma-Aldrich) gradient. After centrifugation, cells at 
the 81/62% interface were recovered and incubated with anti-B220–
coated magnetic beads (Miltenyi Biotec) to remove B cells. More than 90% 
of the remaining cells were Gr-1
+Mac-1
+ mature neutrophils.
Chemotaxis assay
Transwell chemotaxis assays were performed as previously described 
(Fukui et al., 2001), using fMLP (Nacalai Tesque) or C5a (Sigma-Aldrich) 
as chemoattractants. After a 3-h incubation at 37°C, cells migrating to the 
lower chamber were collected and stained with anti–Gr-1 (BD Biosciences) 
and anti-F4/80 (Invitrogen) mAbs. The percentage of migrating neutrophils 
was calculated by dividing the number of Gr-1
+F4/80
− cells in the lower 
chamber by that of the input cells. Analysis was performed with a 
FACSCalibur ﬂ  ow cytometer (Becton Dickinson).
For the chamber chemotaxis assay, BM neutrophils suspended in 
HBSS containing a 1:10 dilution of 10% gelatin were allowed to adhere to 
glass coverslips for 15 min at 37°C. The coverslips were rinsed and placed 
on a Zigmond chamber (Neuroprobes). Aliquots of HBSS containing gela-
tin were added to one side of the chamber and the same solution contain-
ing 10 μM fMLP was added to the other side. Time-lapse video microscopy 
was used to examine neutrophil movement in Zigmond chambers placed on 
a heated stage (37°C). A microscope (model IX70; Olympus) was equipped 
with differential interference contrast optics, and a 20× or 40× objective. 
Images were captured with a camera (CoolSNAP HQ/OL; Photometrics) 
and processed with MetaMorph software (Universal Imaging Corp.).
Superoxide production
BM neutrophils (1 × 10
5) suspended in Hepes-buffered saline containing 
0.03% BSA were stimulated at 37°C with 8 μM fMLP or 200 ng/ml PMA, 
and the reaction was terminated by addition of 50 μg/ml SOD. The che-
miluminescence was counted with an enhancer-containing, luminol-based 
detection system (National Diagnostics) using a luminometer (Auto Lumat 
LB953; Berthold).
Actin polymerization and F-actin localization
BM neutrophils were stimulated with 10 μM fMLP for the speciﬁ  ed times, 
and then ﬁ  xed with 4% paraformaldehyde and 0.1% BSA in PBS. Cells 
were treated with 0.1% Triton X-100, soaked in PBS containing 3% BSA, 
stained with Alexa Fluor 488–conjugated phalloidin (Invitrogen), and ana-
lyzed with a FACSCalibur ﬂ  ow cytometer.
For visualization of F-actin localization, BM neutrophils stimulated in 
suspension with 10 μM fMLP or those chemotaxing under the 10 μM fMLP 
gradient were ﬁ  xed with 4% paraformaldehyde and treated with 0.2% 
  Triton X-100 in PBS. Cells were then soaked in PBS containing 3% BSA and 
stained with Alexa Fluor 546–conjugated phalloidin (Invitrogen). All 
  images were taken with a laser scanning confocal microscope (FLUOVIEW 
FV500; Olympus).
Figure 4.  DOCK2 translocates to the leading edge in a PI3K-dependent 
manner.  (A) BM neutrophils from DOCK2-GFP mice were exposed to 
a   uniform concentration of fMLP (10 μM), with or without pretreatment of 
200 nM wortmannin, and analyzed for the membrane translocation of 
DOCK2 at 15 s. (B) BM neutrophils from DOCK2-GFP mice were stimulated 
with a micropipette containing 10 μM fMLP, in the presence or absence of 
pretreatment of 400 μM LY294002, and analyzed for intracellular DOCK2 
dynamics at 5-s intervals with time-lapse video microscopy. Bars, 10 μm.
Figure 5.  DOCK2 associates with PIP3 through DHR-1. (A) After HA-
tagged DOCK2 was expressed in HEK293T cells with or without ELMO1, 
cell extracts were incubated with PIP3-coated or control beads, and the 
bound proteins were analyzed with an anti-HA antibody. The expression of 
DOCK2 and ELMO1 in total cell lysate (TCL) is shown on the left. (B and C) 
After HA-tagged DOCK2 and ELMO1 were coexpressed in HEK293T cells, 
cell extracts were incubated with (C) or without (B) phosphatidylserine lipo-
somes containing various concentrations of PIP3 before a pull-down experi-
ment using the indicated beads. As a control, PH-Akt-GFP was expressed in 
HEK293T cells and similarly analyzed with anti-GFP antibody. (D) After ei-
ther Flag-tagged DOCK2 or DHR1del was expressed in HEK293T cells 
with ELMO1, cell extracts were incubated with PIP3-coated or control 
beads, and the bound proteins were analyzed with anti-Flag antibody.JCB • VOLUME 174 • NUMBER 5 • 2006  652
Membrane translocation of PH-Akt and DOCK2
BM neutrophils (5 × 10
6) were electroporated with 2.5 μg PH-Akt-GFP 
DNA construct by using the Human Monocyte Nucleofector kit (Amaxa 
  Biosystems) following protocol Y-001, and then placed on a glass-bottom 
microwell dish. At 2 h after transfection, BM neutrophils were exposed to 
a uniform concentration of fMLP or stimulated on a heated stage (37°C) 
with a micropipette containing 10 μM fMLP. Images were taken from 
  either a laser scanning confocal microscope (FLUOVIEW FV500; Olym-
pus) or a microscope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) with 
differential interference contrast and ﬂ  uorescence image capability. The 
intracellular DOCK2 dynamics were similarly analyzed using freshly iso-
lated BM neutrophils from DOCK2-GFP mice with or without pretreatment 
of PI3K inhibitors.
Metabolic cell labeling and lipid extraction
Neutrophils (6–7.5 × 10
7) were labeled with [
32P]orthophosphate in a 
  labeling buffer (136 mM NaCl, 4.9 mM KCl, 5.5 mM glucose, 0.1% 
BSA [fatty acid–free], and 10 mM Hepes-NaOH, pH 7.4) for 1.5 h at 
37°C. Cells were stimulated with 8 μM fMLP or 25 nM C5a for the speci-
ﬁ   ed times. Treatments were quenched by the addition of chloroform/
methanol/8% HClO4 (5:10:4). After vigorous vortexing, chloroform/
HClO4 (1:1) was added to isolate the organic phase, which was washed 
twice in chloroform-saturated 1% HClO4 before drying. Dried lipids were 
resolved in chloroform/methanol (95:5) and separated by thin-layer 
chromatography, or they were deacylated and analyzed by HPLC as 
  previously described (Serunian et al., 1991), using a Partisphere SAX 
  column (Whatman).
Pull-down assay and immunoblotting
Aliquots of the cell extracts were kept for total lysate controls, and the re-
maining extracts were incubated with the GST-fusion, Cdc42/Rac-binding 
domain of PAK1 at 4°C for 60 min. The bound proteins and the same 
amounts of total lysates were analyzed by SDS-PAGE, and blots were 
probed with a mAb 23A8, which preferentially reacts with Rac1 (Upstate 
Biotechnology), Rac2-speciﬁ  c antibody (Santa Cruz Biotechnology, Inc.), 
or Cdc42-speciﬁ  c antibody (Upstate Biotechnology). Activation of Akt was 
assessed with a phosphorylation-speciﬁ   c antibody against Ser473 or 
Thr308 (Cell Signaling Technology).
For lipid-binding assays, HEK293T cells were transfected with the 
speciﬁ  ed plasmid DNAs and suspended in 450 μl of lipid-binding buffer 
(20 mM Tris-HCl, 150 mM NaCl, and 1 mM EDTA, pH 7.5). The cells 
were passed 10 times through a G25 needle and sonicated on ice. After 
insoluble debris was removed by ultracentrifugation at 100,000 g for 
30 min at 4°C, a 20-μl slurry of PIP beads (Echelon Biosciences) and 1% 
NP-40 solution (at a ﬁ  nal concentration 0.25%) were added to the tube 
and incubated for 3 h at 4°C under rotary agitation. The beads were 
washed with lipid-binding buffer supplemented with 0.25% NP-40, and 
the bound proteins were subjected to immunoblotting. For competitive in-
hibition with liposomes, cell extracts were incubated on ice with 200 μM 
phosphatidylserine/PIP3 liposomes for 2 h before addition of PIP3 beads 
and NP-40. Liposome was prepared as follows: phospholipids (Avanti 
Polar Lipids) dissolved in chloroform were mixed and dried down under 
nitrogen. The lipid ﬁ  lm was then resuspended in lipid-binding buffer and 
sonicated on ice.
Online supplemental material
Fig. S1 shows that DOCK2 deﬁ   ciency impairs PMA-induced Rac 
  activation. Fig. S2 shows that lamellipod formation and membrane 
  accumulation of PH-Akt are impaired in DOCK2
−/− neutrophils stimulated 
by a point source of fMLP. Fig. S3 shows that BM neutrophils from B6 and 
DOCK2
−/− mice comparably generate PIP3 in response to C5a. Video 1 
shows a low magniﬁ   cation image for B6 and DOCK2
−/− neutrophils 
chemotaxing under the fMLP gradient. Video 2 shows the migratory be-
havior of B6 and DOCK2
−/− neutrophils chemotaxing under the fMLP 
gradient. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200602142/DC1.
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